Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...

Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...

Chinese drugmaker Qilu Pharmaceutical will be responsible for developing metabolic disease drug candidates from Insilico Medicine under a contract with a total value that "approaches" $120 million, ...

The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional ...

Budget and staffing cuts at the Food and Drug Administration orchestrated by President Donald Trump could prevent new drugs “from being developed, approved, or commercialized in a timely manner, or at ...

Let’s dig into the relative performance of West Pharmaceutical Services (NYSE:WST) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies ...